My Pharmaceutical

View All
April 22, 2021 Off

Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19

By Author

A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The trial, ACTIV-2, is sponsored by the National Institute of Allergy...

April 13, 2021 Off

Drug testing approach uncovers effective combination for treating small cell lung cancer

By Author

Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small...

March 25, 2021 Off

Scientists find evidence that novel coronavirus infects the mouth’s cells

By Author

An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth....